FORO DE RESIDENTES
FR - Procalcitonina: una prueba complementaria extraordinariamente útil en dermatología
RF - Procalcitonin: An extremely useful biomarker in dermatology
I. Marti-Marti, D. Rizo-Potau, D. Morgado-Carrasco
Autor para correspondencia
Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España
Leído
8297
Vecesse ha leído el artículo
2052
Total PDF
6245
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 182 | 31 | 213 |
| 2025 5 | 193 | 36 | 229 |
| 2025 4 | 220 | 37 | 257 |
| 2025 3 | 212 | 40 | 252 |
| 2025 2 | 210 | 53 | 263 |
| 2025 1 | 155 | 30 | 185 |
| 2024 12 | 139 | 41 | 180 |
| 2024 11 | 174 | 60 | 234 |
| 2024 10 | 124 | 49 | 173 |
| 2024 9 | 161 | 54 | 215 |
| 2024 8 | 183 | 64 | 247 |
| 2024 7 | 125 | 57 | 182 |
| 2024 6 | 143 | 41 | 184 |
| 2024 5 | 170 | 58 | 228 |
| 2024 4 | 125 | 35 | 160 |
| 2024 3 | 134 | 42 | 176 |
| 2024 2 | 137 | 42 | 179 |
| 2024 1 | 131 | 45 | 176 |
| 2023 12 | 107 | 32 | 139 |
| 2023 11 | 138 | 41 | 179 |
| 2023 10 | 127 | 44 | 171 |
| 2023 9 | 108 | 29 | 137 |
| 2023 8 | 117 | 20 | 137 |
| 2023 7 | 132 | 35 | 167 |
| 2023 6 | 142 | 18 | 160 |
| 2023 5 | 133 | 34 | 167 |
| 2023 4 | 101 | 35 | 136 |
| 2023 3 | 141 | 49 | 190 |
| 2023 2 | 96 | 31 | 127 |
| 2022 1 | 136 | 64 | 200 |
| 2022 12 | 86 | 63 | 149 |
| 2022 11 | 151 | 43 | 194 |
| 2022 10 | 165 | 46 | 211 |
| 2022 9 | 130 | 51 | 181 |
| 2022 8 | 167 | 64 | 231 |
| 2022 7 | 156 | 67 | 223 |
| 2022 6 | 179 | 78 | 257 |
| 2022 5 | 160 | 53 | 213 |
| 2022 4 | 141 | 34 | 175 |
| 2022 3 | 107 | 45 | 152 |
| 2022 2 | 69 | 23 | 92 |
| 2021 1 | 120 | 55 | 175 |
| 2021 12 | 37 | 34 | 71 |
| 2021 11 | 56 | 36 | 92 |
| 2021 10 | 108 | 66 | 174 |
| 2021 9 | 17 | 47 | 64 |
Mostrar todo
